ATE497005T1 - Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen - Google Patents

Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen

Info

Publication number
ATE497005T1
ATE497005T1 AT97933727T AT97933727T ATE497005T1 AT E497005 T1 ATE497005 T1 AT E497005T1 AT 97933727 T AT97933727 T AT 97933727T AT 97933727 T AT97933727 T AT 97933727T AT E497005 T1 ATE497005 T1 AT E497005T1
Authority
AT
Austria
Prior art keywords
dna
neisseria meningitidis
peptides
production
bacterial species
Prior art date
Application number
AT97933727T
Other languages
English (en)
Inventor
Xavier Nassif
Colin Tinsley
Mark Achtman
Jean-Louis Ruelle
Carla Vinals
Petra Merker
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE497005T1 publication Critical patent/ATE497005T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT97933727T 1996-07-12 1997-07-11 Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen ATE497005T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9608768A FR2751000B1 (fr) 1996-07-12 1996-07-12 Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
PCT/FR1997/001295 WO1998002547A2 (fr) 1996-07-12 1997-07-11 Adn et proteines ou peptides specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques

Publications (1)

Publication Number Publication Date
ATE497005T1 true ATE497005T1 (de) 2011-02-15

Family

ID=9494012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933727T ATE497005T1 (de) 1996-07-12 1997-07-11 Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen

Country Status (11)

Country Link
US (6) US7029845B2 (de)
EP (2) EP0951552B1 (de)
JP (3) JP2001504684A (de)
AT (1) ATE497005T1 (de)
AU (1) AU730423B2 (de)
CA (1) CA2260079C (de)
DE (1) DE69740110D1 (de)
ES (1) ES2365110T3 (de)
FR (1) FR2751000B1 (de)
PT (1) PT951552E (de)
WO (1) WO1998002547A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
EP1047784B2 (de) 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Antigene aus neisseria meningitidis
GB9808734D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
EP2261338A3 (de) * 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
GB9811260D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
GB9820003D0 (en) * 1998-09-14 1998-11-04 Smithkline Beecham Biolog Novel compounds
FR2785293B1 (fr) 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
AU2289000A (en) * 1999-01-15 2000-08-01 Smithkline Beecham Biologicals (Sa) (neisseria meningitidis) polypeptide basb052
AU2288900A (en) * 1999-01-15 2000-08-01 Smithkline Beecham Biologicals (Sa) Novel compounds
EP1144643A1 (de) 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
HK1042515A1 (zh) * 1999-01-22 2002-08-16 Smithkline Beecham Biologicals S.A. 來自腦膜炎球菌的basb055多核苷酸和多肽，其使用法
EP1149164A2 (de) 1999-01-22 2001-10-31 SmithKline Beecham Biologics SA Neisseria meningitidis polypeptide
AU2292800A (en) * 1999-01-22 2000-08-07 Smithkline Beecham Biologicals (Sa) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies
GB9902070D0 (en) * 1999-01-29 1999-03-24 Smithkline Beecham Biolog Novel compounds
EP1163343B1 (de) 1999-03-12 2009-12-09 GlaxoSmithKline Biologicals S.A. Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
JP2004508801A (ja) * 1999-10-29 2004-03-25 カイロン　ソチエタ　ア　レスポンサビリタ　リミタータ ナイセリア抗原性ペプチド
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
ES2519440T3 (es) 2000-07-27 2014-11-07 Children's Hospital & Research Center At Oakland Vacunas para la protección de amplio espectro contra enfermedades causadas por Neisseria meningitidis
US7261901B2 (en) 2001-01-31 2007-08-28 University Of Iowa Research Foundation Vaccine and compositions for the prevention and treatment of neisserial infections
WO2002060936A2 (en) * 2001-01-31 2002-08-08 University Of Iowa Research Foundation Vaccine and compositions for the prevention and treatment of neisserial infections
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0103424D0 (en) 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US20060057160A1 (en) 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
CA2503946C (en) 2002-11-01 2016-08-16 Glaxosmithkline Biologicals S.A. Drying process
EP1667712B1 (de) 2003-10-02 2010-07-21 GlaxoSmithKline Biologicals S.A. B. pertussis antigene und ihre verwendung bei der vakzinierung
WO2006081259A2 (en) 2005-01-27 2006-08-03 Children's Hospital & Research Center At Oakland Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
CA2654706A1 (en) 2006-06-12 2007-12-21 Nathalie Devos Neisseria meningitidis lipooligosaccharide vaccine
CA2792687A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
WO2012059593A1 (en) * 2010-11-05 2012-05-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccines for preventing meningococcal infections
WO2014016152A1 (en) 2012-07-27 2014-01-30 Institut National De La Sante Et De La Recherche Medicale Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS1106A7 (is) 1959-06-29 1959-07-08 C. Van Der Lely N.V. Tæki til að flytja til hliðar uppskeru, sem liggur á jörðinni
WO1988003957A1 (en) * 1986-11-24 1988-06-02 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
RU2023448C1 (ru) * 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
JPH02203800A (ja) * 1988-04-15 1990-08-13 Innogenetics Sa:Nv ナイセリア菌株を検出するための交雑プローブ
AU5851390A (en) * 1989-06-19 1991-01-08 Statens Serum Institut A malaria vaccine
EP0452596A1 (de) * 1990-04-18 1991-10-23 N.V. Innogenetics S.A. Hibridizierungssonden aus dem Abstandsbereich zwischen den 16S- und 23S-rRNA-Genen und Nachweis von nichtviralen Mikroorganismen
US6086896A (en) * 1990-07-16 2000-07-11 Imclone Systems Incorporated Antigenic iron repressible protein from N. meningitidis related to the hemolysin family of toxins
CA2121696C (en) 1991-10-23 2003-07-08 James R. Lupski Fingerprinting bacterial strains using repetitive dna sequence amplification
ATE157703T1 (de) 1991-12-16 1997-09-15 Ciba Geigy Ag Endoplasmatisches retikulum-ständige rekombinante dibasische endoprotease und deren verwendungen
EP0625165A1 (de) * 1992-08-31 1994-11-23 Global Tek, Inc. Monoklonale antikörper gegen das oberflächenprotein des bakteriums neisseria meningitidi
US5445933A (en) * 1992-09-15 1995-08-29 Boehringer Mannheim Corporation Strand displacement assay and complex useful therefor
ZA937220B (en) 1992-09-30 1995-06-30 Cornell Res Foundation Inc Transgenic pomaceous fruit with fire blight resistance
US5436142A (en) * 1992-11-12 1995-07-25 Cold Spring Harbor Laboratory Methods for producing probes capable of distingushing variant genomic sequences
US6401267B1 (en) * 1993-09-27 2002-06-11 Radoje Drmanac Methods and compositions for efficient nucleic acid sequencing
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5698438A (en) * 1994-10-18 1997-12-16 Oregon Health Sciences University Bacterial hemoglobin receptor gene
US5747252A (en) * 1995-06-07 1998-05-05 Gen-Probe Incorporated Nucleic acid probes and amplification oligonucleotides for Neisseria species
CA2223104A1 (en) * 1995-06-07 1996-12-19 Jonathan P. Duvick Pcr-based cdna subtractive cloning method
US6277382B1 (en) * 1995-10-17 2001-08-21 Oregon Health Sciences University Hemoglobin receptors from neisseriae
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
EP1047784B2 (de) * 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Antigene aus neisseria meningitidis
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria

Also Published As

Publication number Publication date
US20020164603A1 (en) 2002-11-07
US20060063167A1 (en) 2006-03-23
EP0951552B1 (de) 2011-01-26
EP0951552A2 (de) 1999-10-27
AU3697797A (en) 1998-02-09
US7368556B2 (en) 2008-05-06
US20070105225A1 (en) 2007-05-10
FR2751000B1 (fr) 1998-10-30
US20110313026A1 (en) 2011-12-22
PT951552E (pt) 2011-05-24
HK1024927A1 (en) 2000-10-27
US7029845B2 (en) 2006-04-18
WO1998002547A3 (fr) 1998-04-09
JP2009291218A (ja) 2009-12-17
ES2365110T3 (es) 2011-09-22
US8357791B2 (en) 2013-01-22
JP2001504684A (ja) 2001-04-10
CA2260079A1 (fr) 1998-01-22
CA2260079C (fr) 2013-05-14
EP2138582A3 (de) 2010-05-05
AU730423B2 (en) 2001-03-08
FR2751000A1 (fr) 1998-01-16
DE69740110D1 (de) 2011-03-10
EP2138582A2 (de) 2009-12-30
EP2138582B1 (de) 2015-04-08
WO1998002547A2 (fr) 1998-01-22
US20090305275A1 (en) 2009-12-10
US20070082361A1 (en) 2007-04-12
JP2009022296A (ja) 2009-02-05

Similar Documents

Publication Publication Date Title
ATE497005T1 (de) Dna und spezifische proteine oder peptide der bakterienspezies neisseria meningitidis, verfahren zu deren herstellung und biologische anwendungen
EP1801219A3 (de) Neissersche Antigenpeptide
PL1626985T3 (pl) Generowanie sztucznych białek wiążących na bazie białek ubikwitynowych
CA2438080A1 (en) Gonococcal proteins and nucleic acids
BR9914374A (pt) Sequências genÈmicas de neisseria e métodos para seu uso
CY1112110T1 (el) Κυκλικο μοριο dna το οποιο διαθετει μια συμβατικη αφετηρια αντιγραφης, η διαδικασια παρασκευης του και η χρηση του στην γονιδιακη θεραπεια
HUP0301659A2 (hu) Kukorica cellulóz-szintetázok és alkalmazásuk
ATE476508T1 (de) Neisseriale antigene
BR9814276A (pt) Antìgenos de superfìcie
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
DK1724354T3 (da) Cirkulær DNA-molekyle med en afhængig replikationsoprindelse, fremgangsmåde til fremstilling heraf og anvendelse heraf i genterapi
DE60041981D1 (de) Neisseria meningitidis-serumgruppen b und c-antigene sowie ein zusätzliches antigen enthaltende zusammensetzungen
WO2000056901A3 (en) Linear and circular expression elements
Wienand et al. Electrophoretic Fractionation and Translation in vitro of Poly (rA)‐Containing RNA from Maize Endosperm: Evidence for Two mRNAs Coding for Zein Protein
BR0213774A (pt) Molécula de ácido nucleio isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
DK0629238T3 (da) Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi
ATE480620T1 (de) Neue pgc-1-isoformen und deren verwendungen
ATE278781T1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
ATE548468T1 (de) Für bakterielle antigene spezifische nukleinsäuremoleküle und ihre verwendung
ATE418604T1 (de) Gegen das prothrombin-fragment f1+2 gerichtete antikörper, ihre herstellung und verwendung
AU2001280639A1 (en) 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
WO2001092495A3 (en) A human lysyl ixodase (47765) and uses thereof
WO2001079489A3 (en) 39228, a human alcohol dehydrogenase and uses therefor
Ruelius et al. Poricin, an acidic protein with antitumor activity from a Basidiomycete: I. Production, isolation, and purification

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0951552

Country of ref document: EP